This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
September 22-25, 2026
Hynes Convention CenterBoston, USA
Menu
Key Sessions
Susan Sharfstein, PhD
KEYNOTE: Clonal variation and modulation of glycosylation in development of a biosimilar
University at Albany
Thomas Seewoester
PLENARY KEYNOTE: From Pipettes to Prompts: Accelerating Biomanufacturing at Exponential Velocity"
Amgen
Tracy Ryan
PLENARY KEYNOTE: From Immune Anarchy to Precision Healing: Sophie’s Journey and the Rise of NKore
NKore BioTherapeutics
Kartik Subramanian, Ph.D.
Room 302: PLENARY KEYNOTE: From Scale to Speed: Building the Next Era of Biologics Innovation
AbbVie
Anthony Davies, Ph.D.
Keynote Panel Discussion: Big Pharma’s CGT Playbook - Top Investment Priorities and Emerging Opportunities
Dark Horse Consulting Group Inc.
keyboard_arrow_right

Tuesday 16th September - Main Conference Day One - ET (Eastern Time, GMT-05:00)

keyboard_arrow_leftSearch & Filter
search
Tuesday 16th September - Main Conference Day One - ET (Eastern Time, GMT-05:00)
search
Showing 2 of 2 Streams
11:10am - 11:15am
Chairperson Remarks: Cell Line Development & Engineering
  • Margaret Lai - Principal Scientist I, Novartis
11:15am - 11:45am
KEYNOTE: Next-Gen CHO “Super” Host with Amino Acid Prototrophy and Metabolic Byproduct-Free Phenotype for Superior Bioprocessing
  • Bhanu Chandra Mulukutla - Research Fellow, BioTherapeutics Pharmaceutical Sciences, Pfizer
11:45am - 12:15pm
Long-lived epigenetically heritable gene expression fluctuations drive biomarkers for industrial cell line development
  • Mark Blenner - Associate Professor, University of Delaware
12:15pm - 12:45pm
Improving Bioprocessing Outcomes with the Next Generation of CHOZN® Host Cell Lines
  • Michael Johns - Senior Scientist, MilliporeSigma
11:10am - 11:15am
Chairperson Remarks: Analytical, Quality and Characterization
  • Ramani Raghavan - Managing Director, Meadowlark BioPharma
11:15am - 11:45am
Room 302: PLENARY KEYNOTE: From Scale to Speed: Building the Next Era of Biologics Innovation
  • Kartik Subramanian, Ph.D. - Vice President Product Development Science and Technology Biologics, AbbVie
11:45am - 12:15pm
Development of High-throughput SEC-MS Methods for Real-time ADC Conjugation Monitoring
  • Zhengqi Zhang - Associate Principal Scientist, Merck
12:15pm - 12:45pm
The Rise of Modular Reagent Manufacturing -- Scalable Solutions to Accelerate Novel Gene Therapy Development
  • Bella Neufeld - VP, Operations, Teknova
Showing 2 of 2 Streams
1:55pm - 2:00pm
Chairperson Remarks: Cell Line Development & Engineering
  • Margaret Lai - Principal Scientist I, Novartis
  • Vishruti Makani - Associate Director – CLD and R&D Support, Shattuck Labs, Inc.
2:00pm - 2:30pm
KEYNOTE: Clonal variation and modulation of glycosylation in development of a biosimilar
  • Susan Sharfstein, PhD - Professor of Nanoscale Science and Engineering, University at Albany
2:30pm - 3:00pm
Novel Technologies to Enhance Antibody Expression, Accelerate Cell Line Development, and Improve Stability in CHO Cells
  • Song Zhiwei - Senior Principal Scientist, Nexa Biologics
3:00pm - 3:30pm
Multiplexing with Accuracy: Building Better CHO Platforms with Cas-CLOVER
  • Corey Brizzee, PhD - Director of Gene Editing, Demeetra
1:55pm - 2:00pm
Chairperson Remarks: Analytical, Quality and Characterization
  • Ramani Raghavan - Managing Director, Meadowlark BioPharma
2:00pm - 3:00pm
PANEL DISCUSSION: Analytical Strategies for Next-Gen Biologics – Aligning Science and Regulation
  • Rajeev Boregowda - Associate Director, Bioassay & Molecular Analytical Development, Genomic Medicine CMC, Sanofi
  • Kevin Zen, PhD - CMC Technical Operations, Opthea
  • Lior Shaltiel - CEO, NurExone Biologic
  • Renée Hart - President & Chief Business Officer, LumaCyte
3:00pm - 3:30pm
Leveraging Analytics to Ensure Stable & Scalable Cell Lines
  • Brett Verstak, PhD - Director, Cell Line Development, Abzena
Showing 2 of 2 Streams
4:30pm - 5:00pm
Advanced expression technology to maximize productivity and product quality
  • Jeffrey Hausfeld - Chairman of the Board, Biofactura
4:30pm - 5:00pm
Roles of Sponsor QA at CMO: Bridging GMP compliance and operational efficiency
  • Wenyan Liao - Principal GMP QA Manager, Pharmaceutical Science Device and Quality, Takeda Pharmaceutical Company Limited
5:00pm - 5:30pm
From Development to Submission: Streamlining CMC Processes
  • Kimberly Larson - Principal Scientist, Boehringer Ingelheim
Monday 15th September: Pre-Conference Day
NextWednesday 17th September - Main Conference Day Two
Filter
Streams
Clear
Choose Day